documents: FDA-2016-N-0001-0051
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2016-N-0001-0051 | FDA | FDA-2016-N-0001 | Advisory Committee; Peripheral and Central Nervous System Drugs Advisory Committee, Renewal | Notice | Notice of Renewal | 2016-05-19T04:00:00Z | 2016 | 5 | 2016-05-19T04:00:00Z | 2016-05-19T14:29:12Z | 2016-11776 | 0 | 0 | 0900006481fdd00c |
Links from other tables
- 1 row from regs_document_id in fr_regs_crossref